NCT06359912View on ClinicalTrials.gov

Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Critical Limb Ischemia

PHASE1RecruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

July 31, 2025

Conditions
Critical Limb Ischemia
Interventions
DRUG

EPCs

IV

BEHAVIORAL

Clinical standard treatment (CST)

Clinical standard treatment

Trial Locations (1)

Unknown

RECRUITING

Hui Shi, Beijing

All Listed Sponsors
collaborator

First Affiliated Hospital Xi'an Jiaotong University

OTHER

lead

Allife Medical Science and Technology Co., Ltd.

INDUSTRY